Acute promyelocytic leukaemia (APL): Difference between revisions
Jump to navigation
Jump to search
DPageNewton (talk | contribs) |
DPageNewton (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
{{ICD10 transition status | {{ICD10 transition status | ||
| OldDxArticle =| CurrentStatus = | | OldDxArticle =| CurrentStatus = reconciled | ||
| InitialEditorAssigned = Debbie Page-Newton | | InitialEditorAssigned = Debbie Page-Newton | ||
| MinimumCombinedCodes = | | MinimumCombinedCodes = | ||
Revision as of 14:41, 13 November 2017
| ICD10 Diagnosis | |
| Dx: | Acute promyelocytic leukaemia (APL) |
| ICD10 code: | C92.4 |
| Pre-ICD10 counterpart: | none assigned |
| Charlson/ALERT Scale: | Any malignancy, including lymphoma and leukemia, except of skin |
| APACHE Como Component: | Immunocompromised |
| APACHE Acute Component: | none |
| Start Date: | |
| Stop Date: | |
| Data Dependencies(Reports/Indicators/Data Elements): | No results |
| External ICD10 Documentation | |
This diagnosis is a part of ICD10 collection.
Additional Info
- Acute promyelocytic leukemia (APML, APL) is a subtype of acute myeloid leukemia (AML), a cancer of the white blood cells.[1]
- In APL, there is an abnormal accumulation of immature granulocytes called promyelocytes. The disease is characterized by a chromosomal translocation involving the retinoic acid receptor alpha (RARα or RARA) gene and is distinguished from other forms of AML by its responsiveness to all-trans retinoic acid (ATRA; also known as tretinoin) therapy.
- Acute promyelocytic leukemia was first characterized in 1957[2][3] by French and Norwegian physicians as a hyperacute fatal illness,[1] with a median survival time of less than a week.[4] Today, prognoses have drastically improved; 10-year survival rates are estimated to be approximately 77% according to one study
Alternate ICD10s to consider coding instead or in addition
Candidate Combined ICD10 codes
(put links to likely candidates coded with this one, eg. a cause for a trauma.)
Related Articles
Show all ICD10 Subcategories